an小安2015-02-26 08:52
$Pharmacyclics(PCYC)$ Pharmacyclics叫价$180亿出售,吸引了JNJ和Novartis。Imbruvica (ibrutinib)估计今年可以卖$10亿。Pharmacyclics成为药界传奇//@新药研发观察: 2015/01/29 FDA 批准ibrutinib (Imbruvica) 用于 华氏巨球蛋白血症 Waldenstrom’s macroglobulinemia 这是继MCL 和CLL后第3个适...查看全文
$Pharmacyclics(PCYC)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2015-05-26 AccNo: 0001104659-15-040557 Size: 80 KB 网页链接
$Pharmacyclics(PCYC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2015-06-10 AccNo: 0000080255-15-000597 Size: 24 KB 网页链接
$Pharmacyclics(PCYC)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2015-06-01 AccNo: 0000921895-15-001510 Size: 53 KB 网页链接
$Pharmacyclics(PCYC)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-05-26 AccNo: 0001193125-15-199336 Size: 38 KB 网页链接
$Pharmacyclics(PCYC)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-05-26 AccNo: 0001193125-15-199335 Size: 38 KB 网页链接
$Pharmacyclics(PCYC)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-05-26 AccNo: 0001193125-15-199334 Size: 38 KB 网页链接
$Pharmacyclics(PCYC)$ CT ORDER - Confidential treatment order Filed: 2015-06-15 AccNo: 9999999997-15-010863 Size: 10 KB 网页链接
$Pharmacyclics(PCYC)$ 8-K - Current report Filed: 2015-05-26 AccNo: 0001104659-15-040558 Size: 109 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem...
$Pharmacyclics(PCYC)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redee Filed: 2015-05-26 AccNo: 0001354457-15-000099 Size: 2 KB 网页链接
$Pharmacyclics(PCYC)$ 15-12G - Securities registration termination [Section 12(g)] Filed: 2015-06-05 AccNo: 0001104659-15-043562 Size: 25 KB 网页链接